Skip to main content
Glama

FDA Recall Alerts — Food & Product Safety (fdarecall)

data_session_query

Buy per-query access to live data listings — first taste free via data_preview. Listing: fdarecall: FDA recall enforcement database (food, drug, device) at 0.01 USDC per query (max 20 queries/session). Sequence: data_session_open → data_session_fund → data_session_query.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
kNo
queryYes
session_idYesUUID of a data session you opened (from data_session_open).
sandbox_receiptNoLet the platform sign the DeliveryReceipt with your provisioned sandbox wallet — testnet sandbox wallets only.
delivery_receiptNo

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. First observed

TDQS

A3.9/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations are sparse (readOnlyHint=false, idempotentHint=false, destructiveHint=false), so the description carries the burden of explaining the paid, consumptive nature of the call. It discloses the 0.01 USDC cost per query, the 20-query session cap, and the specific data listing. It does not cover what happens on failed queries or how results are returned, but the key consumption behavior is transparent and consistent with the annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Three short sentences, each earning its place: the paid-access model, the listing/price/quota, and the required session sequence. Information is front-loaded and no filler is present.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness3/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

The description is strong on selection and sequencing: which listing, what it costs, what to open/fund first, and the free preview route. But without an output schema and with 5 parameters only 40% covered, the missing semantics for k and delivery_receipt, plus unspecified query syntax, leave an agent with gaps for a fully confident call. It is adequate for a basic required-parameter invocation, not complete.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters2/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 40%, so the description needs to compensate for undocumented parameters, but it does not explain k, delivery_receipt, or the expected query format. The only parameter-related context is that the query targets the fdarecall FDA recall listing and that queries are paid/limited. This leaves the central 'query' parameter and the optional k/receipt parameters under-specified for correct invocation.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose4/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description identifies a specific resource (the fdarecall FDA recall listing) and the commercial transaction (per-query paid access), and the sequence line makes clear this tool executes the query step. It is distinguishashable from data_preview, data_session_open, and data_session_fund. However, the core action 'run a query' is stated more in the sequence/schema than in the description's own verb.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It gives an explicit prerequisite sequence: data_session_open -> data_session_fund -> data_session_query, and mentions data_preview as the free first-taste alternative. This tells an agent when to use this tool and what must happen before calling it. No comparable guidance is needed beyond that.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

B3.3/5.0
Disambiguation2/5

The tool set blends FDA recall query tools with generic A2AWire marketplace tools, making purpose boundaries unclear. Multiple tools overlap: data_session_fund, data_session_funding_package, and data_session_open all describe payment/session setup, while a2awire_guide and get_recommended_action both serve as navigational helpers.

Naming Consistency2/5

Some tools follow a verb_noun pattern (data_session_open, data_session_query, discover_agents), but others are inconsistent or vague (a2awire_guide, check_earnings, register, verify_contract). The mix of domain-specific and platform tool naming with no coherent convention makes the surface feel disjointed.

Tool Count2/5

16 tools is not inherently excessive, but most are unrelated to FDA recall alerts; they cover agent registration, onboarding, escrow, hiring, and earnings. Only a handful actually concern the stated FDA recall data domain, so the count is poorly scoped for the server's apparent purpose.

Completeness2/5

For an FDA recall alert server, the surface is severely incomplete: there is no direct recall listing, search, filtering, or detail tool, only a generic data_session_query with preview. The remaining tools are platform infrastructure, leaving the actual recall domain shallow and dependent on an opaque paid query flow.

Resources